Skip to main content

Find Clinical Trials

Home
Conditions
Myotonic Dystrophy

Clinical trial condition

Myotonic Dystrophy

Explore clinical trials studying Myotonic Dystrophy. Study availability and eligibility vary by location and protocol.

107 public trials 36 recruiting studies

Refine in advanced search Browse all conditions

Myotonic Dystrophy trial results

Completed

Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy

NCT02858908

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
Locations: Newcastle-upon-Tyne Hospitals NHS Trust Newcastle upon Tyne, Tyne and Wear, United Kingdom

View Trial Details

Completed

Profile of Dysphagia in Myotonic Dystrophy Type 1 (DM1)

NCT05865483

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Deglutition Disorders, Digestive System Diseases, +17 more
Locations: The National Hospital for Neurology & Neurosurgery, University College London Hospitals London, United Kingdom

View Trial Details

Completed

Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1

NCT05006924

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
Locations: Haukeland University Hospital Bergen, Norway

Oslo University Hispital Oslo, Norway

Frambu Centre for Rare Disorders Siggerud, Norway

View Trial Details

Completed

Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1

NCT04886518

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disorders of Excessive Somnolence, Dyssomnias, +16 more
Locations: UCI Center for Clinical Research Irvine, California, United States

University of Colorado School of Medicine Aurora, Colorado, United States

University of South Florida Tampa, Florida, United States

Rare Disease Research Atlanta, Georgia, United States

View all 13 locations

View Trial Details

Completed

Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy

NCT03059264

Conditions: Congenital Myotonic Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +10 more
Locations: Virginia Commonwealth University Richmond, Virginia, United States

Pediatric Neuromuscular Research, Children's Hospital - LHSC London, Ontario, Canada

Centro Clinico Nemo Milan, Italy

View Trial Details

Completed

Open Label Study in Adolescents and Children With Myotonic Disorders

NCT04624750

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +9 more
Locations: Hôpital Necker-Enfants-Malades Paris, France

View Trial Details

Completed

The Risk of Falls Index for Patients With Neuromuscular Disorders

NCT05890833

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +26 more
Locations: Marko Mijic München, Bavaria, Germany

View Trial Details

Completed

Trial Readiness and Endpoint Assessment in Congenital and Childhood Myotonic Dystrophy

NCT06276244

Conditions: CDM, ChDM, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations: Fondazione Serena Onlus - Centro Clinico NeMO Milano Milan, Italy

View Trial Details

Completed

Technology Assisted Rehabilitation for Upper Limb Function in Myotonic Dystrophy Type 1

NCT05560438

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
Locations: Vikersund Rehabilitation Center Vikersund, Akershus, Norway

View Trial Details

Completed

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

NCT01931644

Conditions: ADD/ADHD, Abnormalities, Multiple, Acquired Immunodeficiency Syndrome, +282 more
Locations: Sanguine Biosciences Los Angeles, California, United States

View Trial Details